Prokineticin receptor 1

Prokineticin receptor 1 (PROKR1) is a G protein-coupled receptor that binds to prokineticins, a family of secreted proteins involved in various physiological processes. This receptor is encoded by the PROKR1 gene located on chromosome 2 in humans.

Structure

PROKR1 is a member of the G protein-coupled receptor (GPCR) family, characterized by seven transmembrane domains. These receptors are integral membrane proteins that transduce extracellular signals through the activation of G proteins. The structure of PROKR1 allows it to interact with its ligands, the prokineticins, and initiate intracellular signaling cascades.

Function

The primary function of PROKR1 is to mediate the effects of prokineticins, which are involved in a variety of biological processes. These include:

• Angiogenesis: PROKR1 plays a role in the formation of new blood vessels, a process crucial for wound healing and tumor growth.
• Inflammation: It is involved in the modulation of inflammatory responses, potentially influencing conditions such as asthma and arthritis.
• Reproductive system: PROKR1 is expressed in the ovary and testis, suggesting a role in reproduction and fertility.
• Circadian rhythm: It may influence the regulation of circadian rhythms, affecting sleep-wake cycles and other physiological processes.

Pathophysiology

Alterations in PROKR1 function or expression have been implicated in several pathological conditions:

• Cancer: Overexpression of PROKR1 has been observed in certain types of cancer, where it may contribute to tumor progression through its pro-angiogenic effects.
• Cardiovascular disease: Dysregulation of PROKR1 signaling can affect blood pressure and vascular tone, potentially leading to hypertension and other cardiovascular disorders.
• Infertility: Mutations or altered expression of PROKR1 may impact reproductive health, leading to infertility or subfertility.

Clinical Significance

Given its involvement in critical physiological processes, PROKR1 is a potential target for therapeutic intervention. Modulating its activity could have implications for treating diseases such as cancer, cardiovascular disorders, and inflammatory conditions.

Research Directions

Ongoing research is focused on understanding the detailed mechanisms of PROKR1 signaling and its interactions with prokineticins. This includes:

• Developing selective agonists and antagonists to modulate PROKR1 activity.
• Investigating the role of PROKR1 in neurobiology and its potential impact on neurological disorders.
• Exploring the genetic variations in the PROKR1 gene and their association with disease susceptibility.

See Also

• Prokineticin receptor 2
• G protein-coupled receptor
• Prokineticin

External Links

• [GeneCards: PROKR1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROKR1)
• [UniProt: Q8NFJ6](https://www.uniprot.org/uniprot/Q8NFJ6)